Despite similar surgical treatment and prophylactic measures (RT ± indomethacin), the risk of HO appears to significantly increase in patients with higher BMI after DAF. Higher single-fraction doses or multiple fractions and/or combination therapy with nonsteroidal inflammatory drugs may be of greater benefit to these patients.
Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS, USA. Waleed246 [at] gmail.com
Int J Radiat Oncol Biol Phys. 2012 Apr;82(5):e831-6
© Galenicom 1999-2013